Raltegravir Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Raltegravir Ethyl [(2-{4-[(4-fluorobenzyl) carbamoyl]-5-hydroxy-1-methyl-6-oxo-1, 6-dihydropyrimidin-2-yl} propan-2-yl) amino] (oxo)acetate VE0010857View
Raltegravir Methyl 5-methyl-1, 3, 4-oxadiazole-2-carboxylate VE0010865View CAS 37641-35-3
Raltegravir N-(4-fluorobenzyl)-2-(2-{[hydrazinyl(oxo)acetyl] amino} propan-2-yl)-5-hydroxy-1-methyl-6-oxo-1, 6-dihydropyrimidine-4-carboxamide VE0010866View
Raltegravir N-(4-fluorobenzyl)-2-(2formamidopropan-2-yl)-5hydroxy-1-methyl-6-oxo1, 6-dihydropyrimidine-4carboxamide VE0010867View
Raltegravir N-(4-fluorobenzyl)-5-methoxy-2-(2-{[(5-methyl-1, 3, 4-oxadiazol-2-yl) carbonyl] amino} propan-2-yl)-6-oxo-1, 6-dihydropyrimidine-4-carboxamide VE0010859View
Raltegravir N1, N2-bis[1-[4-[[[(4-Fluorophenyl)methyl]amino]carbonyl]-1, 6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]ethanediamide VE0010863View CAS 1391918-18-5
Raltegravir Raltegravir Diketo Ethoxy Impurity VE0010899View CAS 1193687-88-5
Raltegravir Raltegravir Diketo Methoxy Impurity VE0010107View CAS 518048-04-9
Raltegravir Raltegravir EP Impurity A VE006978View CAS 518048-03-8
Raltegravir Raltegravir EP Impurity C VE0010855View CAS 1391918-17-4
Raltegravir Raltegravir EP Impurity D VE006979View CAS 1064706-98-4
Raltegravir Raltegravir EP Impurity E VE006980View CAS 1193687-87-4
Raltegravir Raltegravir EP Impurity F VE0010910View CAS 2138805-56-6
Raltegravir 5-methyl-1, 3, 4-oxadiazole-2-carboxamide VE0010856View CAS 99367-45-0

Request a quote

1064706-98-4: Raltegravir EP Impurity D

1064706-98-4: Raltegravir EP Impurity D
Catalogue No.

VE006979

CAS No.

1064706-98-4

Molecular Formula

C18H19FN4O6

Molecular Weight

406.37 g/mol

Parent drug

Raltegravir

IUPAC Name

2-(2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1, 6-dihydropyrimidin-2-yl)propan-2-ylamino)-2-oxoacetic acid

Synonyms

Raltegravir Oxalyl Analog

Smile
References

Mouscadet, Jean-François, and Luba Tchertanov. “Raltegravir: Molecular Basis of Its Mechanism of Action.” European Journal of Medical Research, vol. 14, no. Suppl 3, 2009, p. 5, https://doi.org/10.1186/2047-783x-14-s3-5. ?

Status

In-stock

ListName

Raltegravir EP Impurity D

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url